Twitxy Saved

Syed A Hussain

@ProfSyedHussain

Professor of Medical Oncology Department of Oncology and Metabolism Medical School, Beech Hill Road, Sheffield
University of Sheffield sheffield.ac.uk/oncology-metab… Joined August 2016
573 Following 849 Followers 722 Posts

Latest posts 5

Syed A Hussain @ProfSyedHussain
Petros Grivas Verified account @PGrivasMDPhD Oct 25
Fantastic to see colleagues, friends @myESMO #ESMO26 united in our vision to tackle cancer & improve outcomes globally!
@ASCOPres @MyriamChalabi @RebeccaDSing @DrChoueiri @tompowles1 @PBarataMD @amanda_psyrri @ProfSyedHussain @VivekSubbiah @StephenVLiu @OncoAlert @dr__mukherji
View quoted post on X
0 replies 3 reposts 21 likes 756 views View on X
Syed A Hussain @ProfSyedHussain
Great to be part of this meeting in Santander today. Thanks for the invitation.
Excellent debates and platform to drive the field forward. Enjoyed great discussions. @PGrivasMDPhD @nachoduranm @giannatempopatr @cdanicas @drenriquegrande @dralvaropinto @docjavip @Uro_Oncologist
GO Norte @gonorte_ Oct 8
🧬 Let’s begin an international session talking about #MIBC 🧅 #GONorteGUdebates
View quoted post on X
0 replies 6 reposts 22 likes 510 views View on X
Syed A Hussain @ProfSyedHussain
It was my pleasure and privilege to contribute to this exciting meeting. Many thanks @DrRafii_OncDoc @OncBrothers @SuyogCancer @ShrutiPatelMD @OncoAlert @oncodaily #EOS2026
Day 1 of our EOS Annual Conference wrapped up on a high note, surrounded by friends and colleagues @OncBrothers @SuyogCancer @ShrutiPatelMD @ProfSyedHussain.

Thank you all for your valuable insights and for making the day so enriching. Looking forward to Day 2! #EOS2026
View quoted post on X
0 replies 1 reposts 14 likes 724 views View on X
Syed A Hussain @ProfSyedHussain
Great news for our patients. Well done Tom etal and the global GU colleagues and our patients who participated in this study and made it happen. At times, Less is more! @tompowles1 @MattGalsky @DrRosenbergMSK @DrChoueiri @DrYukselUrun @myESMO @kalasri3 @OncoAlert @TUOS_Cancer
Tom Powles Verified account @tompowles1 Sep 25
FDA grants Priority Review for the VOLGA trail, in which 3 neoadjuvant cycles of EV and a year of Perioperative durvalumab was given for patients with muscle invasive bladder cancer. Press release states an EFS and OS advantage. Data will be presented #ESMO26 @OncoAlert @myESMO @Annals_Oncology astrazeneca-us.com/content/az-us/…
View quoted post on X